PROVIDER PROFILE · NPI 1528280864

Armine TumyanMD

RheumatologyPlano, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,460

Unique beneficiaries

—

Total services

40,259

Distinct HCPCS

Medicare payment

$395K

Peer benchmark

Total Medicare services vs. 382 Rheumatology providers in TX — above median (cohort median 13,742).

PRESCRIBING · PART D · 2024

Total Rx claims

3,239

Beneficiaries

—

Total drug cost

$3.1M

Distinct drugs

Brand share

35.4%

Top prescribed drugs

Prednisone549 claims

Methotrexate Sodium518 claims

Hydroxychloroquine Sulfate499 claims

Leflunomide143 claims

Alendronate Sodium127 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$60

Payment records

By payment type

Food and Beverage$60

Top paying entities

Food and Beverage$60

REFERRAL NETWORK

Where Armine Tumyan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	107	419
CRESCENDO BIOSCIENCE, INC	57	149
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	22	47
Su Yin Rheumatology · Plano, TX	18	34
Christina Hagood Nurse Practitioner · Dallas, TX	15	29
Pathologists Bio-Medical Laboratories Pllc Clinical Laboratory · Coppell, TX	12	38

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history